Skip to content

Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder

A Randomized Controlled Trial on the Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder Treated at Asker DPS as Outpatients or Inpatients at Blakstad Hospital

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06197048
Enrollment
40
Registered
2024-01-09
Start date
2023-09-25
Completion date
2028-12-01
Last updated
2024-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder, Cardiovascular Diseases, Psychosis, Schizophrenia

Keywords

Severe mental disorders, Nutritional counseling, Cardiovascular disease, Schizophrenia, Bipolar affective disorder, Randomzied controlled trial

Brief summary

The goal of this clinical trial is to compare the effect of nutritional counseling versus no treatment in patients with schizophenia or bipolar affective disorder. The main question it aims to answer are: • Can nutritional counseling have a preventive effect on the development of cardiovascular disease in patients with schizophenia or bipolar affective disorder? Participants will meet a nutritionist at baseline to asess nutritional status, biochemical and anthropometric measurements. Then, half of the study population will receive nutritional counseling. After six weeks, the same baseline measurements will be repeated to examine any potential differences between the two groups. After the intervention, the control group will be offered the same counseling as the intervention group received during the study.

Detailed description

People with severe mental illness have a shorter life expectancy compared to the general population. Individuals with schizophrenia or bipolar affective disorder have an estimated reduce life expectancy by an average of 10-20 years. Increased mortality is caused by many factors, but cardiovascular diseases contributes the most. Increased prevalence of cardiovascular disease is mainly due to a poor lifestyle, which includes smoking, physical inactivity and an unhealthy diet. It is important to find treatment that can provide better quality of life and longer life expectancy in these patient groups. Few clinical studies have been conducted on the effect of nutritional counseling on biochemical and anthropometric measurements related to cardiovascular diseases. Therefore, we want to investigate this through a randomized controlled trial.

Interventions

BEHAVIORALNutritional counseling

The intervention group will recieve 30 x 2 minutes with nutritonal counseling seperatet by a 15 minutes break. The participants will receive individually tailored guidance based on the information recieved at baseline measurments. The couseling will be based on the Norwegian goverments dietary advices and the recommendation from the Directorate of Health for the prevention of cardiovascular diseases.

Sponsors

University of Oslo
CollaboratorOTHER
Vestre Viken Hospital Trust
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

the included patients will be randomized into two groups: one croup will receive nutritional counseling, while the other does not. All the participants will complete baseline and post-intervention measurements consisting of: mapping of diet, anthropometric measurements (weight, height, waist measurement), bloodpressure, biochemical measurements (total cholesterol, non-HDL cholesterol, LDL cholesterol, triglycerides, vitamin D, ferritin, fasting glucose, HbA1c, folate and AST/ALT. Then the two groups will be compared to reveal any differences.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \> 18 years * Diagnosed with either schizophrenia/psychosis or bipolar affective disorder * Patients treatet in Vestre Viken healthcare company, at either Asker district psychiatric center or Blakstad hospital

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
Non-HDL cholesterol6 weeksHDL-cholesterol - total cholesterol, biochemical test

Secondary

MeasureTime frameDescription
total cholesterol6 weeksbiochemical test
HDL-cholesterol6 weeksbiochemical test
Triglycerids6 weeksbiochemical test
HbA1c6 weeksbiochemical test
ALT AST/ALT AST/ALT6 weeksbiochemical test
fasting glucose6 weeksbiochemical test
Food frequency questionnaire6 weeksquestionnaire
Folate6 weeksbiochemical test
LDL-cholesterol6 weeksbiochemical test
Weight6 weeksanthropometric measurement
waist circumference6 weeksanthropometric measurement
Bloodpressure6 weeks
24-hour dietary recall6 weeksinterview
Vitamin D6 weeksbiochemical test

Countries

Norway

Contacts

Primary ContactDawn E Peleikis, phD
dawn.peleikis@vestreviken.no+4799405812
Backup ContactCamilla N Myrdal, Master
camilla.myrdal@studmed.uio.no+4794814040

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026